Nasdaq, Inc. reports developments across its market infrastructure, index, data, listings and financial technology businesses. Company news commonly covers monthly trading volumes, quarterly volume and listings statistics, earnings releases, dividend announcements, and operating trends in divisions such as Financial Technology.
Nasdaq updates also include changes to the Nasdaq-100 Index and other Nasdaq Global Indexes, trading halt and resumption notices from The Nasdaq Stock Market, and corporate governance or capital-structure matters. Its financial technology activities include solutions tied to capital management, financial crime and regulatory compliance software.
Summary not available.
The Board of Directors of Nasdaq has declared a quarterly dividend of $0.22 per share, marking a 10% increase from the previous quarter. This dividend is payable on June 30, 2023, to shareholders who are on record by June 16, 2023. Future declarations of dividends will depend on Board approval. Nasdaq is a global technology company that provides data, analytics, software, and services to capital markets and other industries, reflecting its commitment to client success.
Nasdaq reported a 2% increase in net revenues for Q1 2023, totaling $914 million, driven by a 4% rise in Solutions businesses. Annualized Recurring Revenue (ARR) grew by 7% to $2.035 billion, with SaaS revenues up 11%, now comprising 36% of ARR. Notably, Anti-Financial Crime revenue surged 17%. GAAP diluted EPS increased 7% to $0.61, while non-GAAP EPS rose 5% to $0.69. The company returned $257 million to shareholders through share repurchases and dividends. Nasdaq signed significant clients for its fraud detection solutions, including a Tier 1 global bank. Additionally, it plans to continue cloud migration and has updated its non-GAAP operating expense guidance for 2023 to $1.78-$1.84 billion.
Summary not available.
Nasdaq has introduced significant upgrades to its Nasdaq Risk Platform, aimed at enhancing its risk management capabilities for banking and broker-dealer clients. This update includes the addition of fixed income securities such as Government and Corporate Bonds, enhancing the platform's ability to deliver real-time analytics for better liquidity and market risk management.
Over the past year, the number of customers utilizing the Nasdaq Risk Platform has surged by over 50%. The upgrades include improved multi-factor stress testing tools and integration of live streaming analytics via an open-source system called Kafka. These enhancements are designed to help firms navigate heightened market volatility and are part of Nasdaq's ongoing growth strategy within its Marketplace Technology segment.
The Nasdaq Stock Market has announced the delisting of several companies, including Core Scientific, The Very Good Food Company, HyreCar, Reeds, Sorrento Therapeutics, CYREN, Lucira Health, Qutoutiao, and Sio Gene Therapies. The securities of these companies have faced trading suspensions since early 2023, with Core Scientific being suspended since January 3. The delistings will be formalized through the filing of a Form 25 with the SEC, becoming effective 10 days post-filing. Investors are encouraged to review public filings for additional insights regarding the basis for these delistings.
On April 10, 2023, Nasdaq (NDAQ) reported its monthly and quarterly trading volumes as well as estimated revenue capture for March 2023. The data is accessible on its investor relations website. The quarterly report includes the number of listings and index statistics for the period ending March 31, 2023. This update reflects Nasdaq's operational performance in the capital markets sector, emphasizing its ongoing commitment to providing valuable financial services and data solutions. Nasdaq continues to evolve within the financial landscape by leveraging technology to serve its clients effectively. For detailed statistics, stakeholders are encouraged to visit Nasdaq's investor relations page.
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) will ring the Nasdaq closing bell to celebrate its 2022 IPO. President and CEO Maria Zannes expressed gratitude for the opportunity, highlighting milestones leading to the launch of its noninvasive cancer detection product, CyPath® Lung. This test is aimed at early-stage lung cancer detection, enhancing treatment effectiveness and patient outcomes. The closing bell ceremony will be streamed live on various platforms, showcasing bioAffinity's commitment to innovation in early cancer diagnostics.
Nasdaq (NDAQ) has appointed Ato Garrett as Senior Vice President and Investor Relations Officer, effective immediately. He will report to Ann Dennison, the Executive Vice President and CFO of Nasdaq. Garrett brings extensive experience from Veeva Systems and major financial institutions, enhancing Nasdaq's global investor relations strategy. Dennison emphasized Garrett's expertise will help articulate Nasdaq's strategy and growth opportunities. Garrett expressed enthusiasm for joining Nasdaq during a pivotal time, focusing on improving liquidity and integrity within the global economy.
Summary not available.